DiaMedica Therapeutics In... (DMAC)
6.28
-0.25 (-3.83%)
At close: Mar 03, 2025, 3:59 PM
6.21
-1.11%
After-hours: Mar 03, 2025, 04:00 PM EST
DiaMedica Therapeutics Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 |
| Revenue | n/a | n/a | n/a | n/a | n/a | 500K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 160.62K | 25.74K | 25.68K | 33.88K |
| Cost of Revenue | 30K | 25K | 24K | 21K | 21K | n/a | 4K | 2.21K | 4.46K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | -30K | -25K | -24K | -21K | -21K | 500K | -4K | -2.21K | -4.46K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 160.62K | 25.74K | 25.68K | 33.88K |
| Operating Income | -21.27M | -14M | -13.65M | -12.7M | -11.59M | -6.76M | -4.52M | -2.48M | -1.31M | -4.83M | -7.43M | -10.11M | -6.71M | -3.84M | -2.4M | -1.69M | -2.31M | -787.21K | -203.01K | -603.43K |
| Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.73K | 1.74K | 10.54K | 14.73K | 41.03K | 51.44K | n/a | n/a | n/a | n/a | n/a | n/a | -0.25 |
| Pretax Income | -19.34M | -13.65M | -13.56M | -12.27M | -10.62M | -5.65M | -4.26M | -2.2M | -1.43M | -4.78M | -7.41M | -10.05M | -6.61M | -4.27M | -2.44M | -1.85M | -2.31M | n/a | -192.73K | -570.16K |
| Net Income | -19.38M | -13.68M | -13.59M | -12.29M | -10.65M | -5.73M | -4.26M | -2.22M | -1.44M | -4.82M | -7.41M | -10.05M | -6.61M | -4.27M | -2.44M | -1.85M | -2.33M | -778.02K | -210.6K | -640.02K |
| Selling & General & Admin | 8.16M | 6.16M | 4.88M | 4.39M | 3.69M | 2.74M | 1.31M | 718.04K | 423.35K | 1.12M | 2.54M | 2.53M | 2.08M | 1.3M | 1M | 618.54K | 1.38M | 192.37K | 177.78K | 168.91K |
| Research & Development | 13.11M | 7.84M | 8.77M | 8.31M | 7.9M | 4.52M | 3.21M | 1.76M | 886.07K | 3.71M | 3.78M | 5.21M | 2.33M | 803.98K | 1.37M | 1.04M | 1.07M | 617.26K | 22.75K | 462K |
| Other Expenses | n/a | 353K | 82K | -205K | -856K | -68K | 6K | 221.9K | 3K | n/a | n/a | n/a | n/a | n/a | 6.58K | -4.89K | n/a | n/a | n/a | n/a |
| Operating Expenses | 21.27M | 14M | 13.65M | 12.49M | 10.74M | 6.05M | 4.28M | 2.48M | 1.31M | 4.83M | 7.43M | 10.11M | 6.71M | 3.84M | 2.4M | 1.69M | 2.47M | 812.95K | 228.69K | 637.31K |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 48.38K | 43.95K | n/a | 7.73K | 2.72K | 12.57K | n/a | n/a | n/a | n/a | n/a | 7.6K | 36.59K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 21.27M | 14M | 13.65M | 12.49M | 10.74M | 6.05M | 4.28M | 2.48M | 1.31M | 4.83M | 7.43M | 10.11M | 6.71M | 3.84M | 2.4M | 1.69M | 2.47M | 812.95K | 228.69K | 637.31K |
| Income Tax | 43K | 28K | 28K | 27K | 31K | 80K | -9K | 22.31K | 12.45K | 42.28K | 7.73K | 2.72K | 12.57K | 499.08K | 41.69K | 163.43K | 20.2K | -9.19K | 17.87K | 69.86K |
| Shares Outstanding (Basic) | 32.57M | 26.44M | 20.77M | 15.68M | 11.99M | 7.74M | 5.94M | 4.74M | 3.62M | 3.11M | 2.73M | 2.45M | 2.26M | 1.43M | 960.48K | 909.72K | 802.3K | 876.03K | 420.15K | 272.16K |
| Shares Outstanding (Diluted) | 32.57M | 26.44M | 20.77M | 15.68M | 11.99M | 7.74M | 5.94M | 4.74M | 3.62M | 3.11M | 2.73M | 2.45M | 2.26M | 1.43M | 960.48K | 909.72K | 802.3K | 876.03K | 420.15K | 272.16K |
| EPS (Basic) | -0.6 | -0.52 | -0.65 | -0.78 | -0.89 | -0.74 | -0.72 | -0.47 | -0.4 | -1.55 | -2.71 | -4.11 | -2.93 | -2.98 | -2.54 | -2.04 | -2.91 | -0.89 | -0.5 | -2.35 |
| EPS (Diluted) | -0.6 | -0.52 | -0.65 | -0.78 | -0.89 | -0.74 | -0.72 | -0.47 | -0.4 | -1.55 | -2.71 | -4.11 | -2.93 | -2.98 | -2.54 | -2.04 | -2.91 | -0.89 | -0.5 | -2.35 |
| EBITDA | -19.31M | -13.98M | -13.62M | -12.24M | -10.6M | -5.64M | -4.26M | -2.15M | -1.5M | -5.01M | -6.51M | -7.7M | -4.51M | -3.32M | -2.27M | -2.34M | -2.29M | -783.89K | -190.26K | -630.3K |
| Depreciation & Amortization | 30K | 25K | 24K | 21K | 21K | 15K | 4K | 2.21K | 4.11K | 2.47K | 1.11M | 2.37M | 2.3M | 1.67M | 30.2K | 26.74K | 18.35K | 3.32K | 28.15K | 6.41K |